Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats

被引:18
作者
Al-Harbi, Naif O. [1 ]
Imam, Faisal [1 ]
Alharbi, Mohammad Matar [1 ]
Khan, Mohammad Rashid [1 ]
Qamar, Wajhul [2 ]
Afzal, Muhammad [3 ]
Algahtani, Mohammad [1 ]
Alobaid, Saad [1 ]
Alfardan, Ali Salim [1 ]
Alshammari, Abdulrahman [1 ]
Albekairi, Thamer H. [1 ]
Alharbi, Khalid Saad [3 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Post Box 2455, Riyadh 11451, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Res Ctr, Dept Pharmacol & Toxicol,Cent Lab, POB 2457, Riyadh 11451, Saudi Arabia
[3] Jouf Univ, Coll Pharm, Dept Pharmacol, Sakakah 72341, Saudi Arabia
关键词
Nephrotoxicity; Protein expression; ELISA; Rivaroxaban; Sunitinib; Antioxidant; SINGLE-CENTER EXPERIENCE; INDUCED NEPHROTOXICITY; KIDNEY; CANCER; DYSFUNCTION; CATALASE; DISEASES; SU11248; FAILURE; CELLS;
D O I
10.1007/s11239-020-02123-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rivaroxaban (RIVA) inhibits factor Xa and exhibits antithrombotic and anti-inflammatory activities by inhibiting several cellular signaling molecules. Sunitinib (SUN) is FDA approved first-line drug for metastatic renal cancers and advanced cancerous states of gastrointestinal tract. Present hypothesis was aimed to examine the nephroprotective potential of RIVA in SUN-induced nephrotoxicity, mediated through the inhibition of oxidative stress-induced apoptosis and inflammation, via the TNF-alpha/NFk-B signaling pathways. Wistar rats 200-250 g were selected and divided randomely in 5 groups (n = 6): Group 1 kept as normal control; Group 2 as disease control and exposed to SUN 50 mg/kg thrice-weekly upto 21 days; Groups 3 and 4, were treatment groups and administered SUN 50 mg/kg thrice-weekly as of group 2 and treated with RIVA 5 and 10 mg/kg/daily for 21 days, respectively; and Group 5 fed with RIVA alone (10 mg/kg/daily for 21 days). Serum was separated from blood to estimate serum biochemical parameters and kidney tissues were collected to estimate antioxidant enzyme, mRNA and protein expression. SUN exposure significantly elevated levels of creatinine, urea, uric acid, blood urea nitrogen, albumin, and bilirubin, and decreased serum magnesium and iron levels. Malondialdehyde and catalase levels were significantly increased and glutathione and glutathione reductase levels were significantly decreased. Intracellular levels of caspase-3 and TNF-alpha were significantly increased; RIVA treatment restored the altered levels. In SUN-exposed animals, western blotting revealed significantly elevated NFk-B, IL-17, and MCP-1 expression, and IKB alpha levels were significantly downregulated; RIVA restored these levels to normal values.RIVA treatment significantly restored the apoptotic and inflammatory parameters in SUN-damaged renal tissues. [GRAPHICS] .
引用
收藏
页码:361 / 370
页数:10
相关论文
共 43 条
  • [11] Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats
    Fujiwara, Yuki
    Ando, Hitoshi
    Ushijima, Kentaro
    Horiguchi, Michiko
    Yamashita, Chikamasa
    Fujimura, Akio
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 134 (04) : 234 - 238
  • [12] Renal prothrombin: Quantification of mRNA using reverse transcription-polymerase chain reaction in a rat model
    Grover, PK
    Miyazawa, K
    Ryall, RL
    [J]. ELECTROPHORESIS, 2004, 25 (06) : 797 - 803
  • [13] Renal Effects of Anti-angiogenesis Therapy: Update for the Internist
    Gurevich, Faina
    Perazella, Mark A.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04) : 322 - 328
  • [14] Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice
    Hara, Tomoya
    Fukuda, Daiju
    Tanaka, Kimie
    Higashikuni, Yasutomi
    Hirata, Yoichiro
    Nishimoto, Sachiko
    Yagi, Shusuke
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Sata, Masataka
    [J]. ATHEROSCLEROSIS, 2015, 242 (02) : 639 - 646
  • [15] Renal failure associated with cancer and its treatment: An update
    Humphreys, BD
    Soiffer, RJ
    Magee, CC
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01): : 151 - 161
  • [16] Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
    Ishibashi, Yuji
    Matsui, Takanori
    Ueda, Seiji
    Fukami, Kei
    Yamagishi, Sho-ichi
    [J]. CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [17] Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation
    Jhaveri, Kenar D.
    Shah, Hitesh H.
    Patel, Chinmay
    Kadiyala, Aditya
    Stokes, Michael B.
    Radhakrishnan, Jai
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (01) : 48 - 55
  • [18] Nephrotoxicities Associated with the Use of Tyrosine Kinase Inhibitors: A Single-Center Experience and Review of the Literature
    Jhaveri, Kenar D.
    Flombaum, Carlos D.
    Kroog, Glenn
    Glezerman, Ilya G.
    [J]. NEPHRON CLINICAL PRACTICE, 2011, 117 (04): : C312 - C319
  • [19] Ameliorative effect of Elaeocarpus ganitrus on gentamicin-induced nephrotoxicity in rats
    Kakalij, Rahul Motiram
    Alla, Chaitanya P.
    Kshirsagar, Rahul P.
    Kumar, Boyina Hemanth
    Mutha, Sumeet S.
    Diwan, Prakash Vamanrao
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (03) : 298 - 302
  • [20] Drug-Induced Nephrotoxicity and Its Biomarkers
    Kim, Sun Young
    Moon, Aree
    [J]. BIOMOLECULES & THERAPEUTICS, 2012, 20 (03) : 268 - 272